Have your own idea? Try our Stock Screener
Polish (WIG) Clinical Research and Equipment Industry Analysis
UpdatedApr 17, 2026
DataAggregated Company Financials
Companies4
- 7D7.8%
- 3M-18.1%
- 1Y-2.7%
- YTDn/a
In the last week, the Clinical Research and Equipment industry is up 6.8%, with Selvita leading the way, up 8.7%. The industry has been flat over the past 12 months despite the gain this week. Looking forward, earnings are forecast to grow by 32% annually.
Industry Valuation and Performance
Has the Polish Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 17 Apr 2026 | zł1.2b | zł459.0m | -zł102,646,524.00 | 760.9x | -12x | 2.7x |
| Sun, 15 Mar 2026 | zł1.3b | zł464.6m | -zł124,641,157.00 | n/a | -10.7x | 2.9x |
| Tue, 10 Feb 2026 | zł1.4b | zł464.6m | -zł124,641,157.00 | n/a | -11.2x | 3x |
| Thu, 08 Jan 2026 | zł1.5b | zł464.6m | -zł124,641,157.00 | n/a | -12.3x | 3.3x |
| Sat, 06 Dec 2025 | zł1.6b | zł464.6m | -zł124,641,157.00 | n/a | -12.7x | 3.4x |
| Mon, 03 Nov 2025 | zł1.3b | zł507.6m | -zł114,663,001.00 | 1456.6x | -11.4x | 2.6x |
| Wed, 01 Oct 2025 | zł1.4b | zł507.7m | -zł114,663,001.00 | 1507.9x | -12.5x | 2.8x |
| Fri, 29 Aug 2025 | zł1.4b | zł460.9m | -zł129,094,851.00 | 37.8x | -11.2x | 3.1x |
| Sun, 27 Jul 2025 | zł1.6b | zł461.1m | -zł128,888,382.00 | 40.8x | -12.1x | 3.4x |
| Tue, 24 Jun 2025 | zł1.3b | zł457.8m | -zł130,948,382.00 | n/a | -10.1x | 2.9x |
| Thu, 22 May 2025 | zł1.5b | zł448.2m | -zł125,701,382.00 | n/a | -12x | 3.4x |
| Sat, 19 Apr 2025 | zł1.4b | zł452.3m | -zł123,092,243.00 | 49.3x | -11.7x | 3.2x |
| Mon, 17 Mar 2025 | zł1.5b | zł440.9m | -zł62,900,243.00 | 32.4x | -24.1x | 3.4x |
| Wed, 12 Feb 2025 | zł1.7b | zł427.0m | -zł64,267,017.00 | 15.5x | -26.3x | 4x |
| Fri, 10 Jan 2025 | zł2.0b | zł427.0m | -zł65,964,174.00 | 16.1x | -29.6x | 4.6x |
| Sun, 08 Dec 2024 | zł2.3b | zł426.9m | -zł66,065,174.00 | 18.1x | -35.3x | 5.5x |
| Tue, 05 Nov 2024 | zł2.2b | zł413.2m | -zł64,500,689.00 | 20.6x | -34.7x | 5.4x |
| Thu, 03 Oct 2024 | zł2.3b | zł413.2m | -zł57,384,869.00 | 22.3x | -40.5x | 5.6x |
| Sat, 31 Aug 2024 | zł2.5b | zł413.4m | -zł37,576,869.00 | 18.8x | -67.3x | 6.1x |
| Mon, 29 Jul 2024 | zł2.5b | zł413.5m | -zł32,092,283.00 | 18.4x | -77.1x | 6x |
| Wed, 26 Jun 2024 | zł2.5b | zł413.5m | -zł32,092,283.00 | 18.9x | -76.7x | 6x |
| Fri, 24 May 2024 | zł2.6b | zł413.5m | -zł32,092,283.00 | 20.2x | -81.8x | 6.3x |
| Sun, 21 Apr 2024 | zł2.6b | zł421.0m | -zł26,364,957.00 | 18.4x | -98x | 6.1x |
| Tue, 19 Mar 2024 | zł2.5b | zł478.9m | -zł71,866,957.00 | 45.5x | -35.2x | 5.3x |
| Thu, 15 Feb 2024 | zł2.5b | zł494.7m | -zł51,178,957.00 | 45x | -49.8x | 5.1x |
| Sat, 13 Jan 2024 | zł2.5b | zł495.2m | -zł50,454,191.00 | 47.3x | -49.5x | 5x |
| Mon, 11 Dec 2023 | zł2.5b | zł495.2m | -zł50,454,191.00 | 45.2x | -49.5x | 5x |
| Wed, 08 Nov 2023 | zł2.6b | zł512.0m | -zł37,354,934.00 | 31.7x | -68.3x | 5x |
| Fri, 06 Oct 2023 | zł2.8b | zł515.2m | -zł43,569,514.00 | 39.9x | -63.9x | 5.4x |
| Sun, 03 Sep 2023 | zł2.8b | zł507.8m | -zł51,598,105.00 | 42.7x | -53.9x | 5.5x |
| Tue, 01 Aug 2023 | zł2.9b | zł512.4m | -zł61,559,268.00 | 46.8x | -46.8x | 5.6x |
| Thu, 29 Jun 2023 | zł2.7b | zł512.4m | -zł61,559,268.00 | 42.8x | -44.4x | 5.3x |
| Sat, 27 May 2023 | zł2.9b | zł507.5m | -zł59,821,034.00 | 46.9x | -48.6x | 5.7x |
| Mon, 24 Apr 2023 | zł2.8b | zł505.4m | -zł64,921,034.00 | 67.2x | -43.3x | 5.6x |
Price to Earnings Ratio
-43.3x
Current Industry PE
- Investors are pessimistic on the Polish Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 4.5x is higher than the industry's current PS ratio of 2.7x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Revenues have also declined 3.2% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does Polish Clinical Research and Equipment compare with similar industries?
| PL Market | 2.31% | |
| Healthcare | 3.84% | |
| Life Sciences | 7.80% | |
| Clinical Research and Equipment | 7.80% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SLV Selvita | zł33.70 | 8.7% +zł49.6m | 10.9% | PE760.9x | |
| RVU Ryvu Therapeutics | zł25.00 | 8.5% +zł45.1m | -12.0% | PS6.6x | |
| NNG NanoGroup | zł2.52 | 1.4% +zł1.1m | -29.0% | PB7.6x |